Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
about
PATHOME: an algorithm for accurately detecting differentially expressed subpathways.Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells.Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction.HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.Tumor angiogenesis revisited: Regulators and clinical implications.Hypoxia and Reactive Oxygen Species Homeostasis in Mesenchymal Progenitor Cells Define a Molecular Mechanism for Fracture Nonunion.Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.Upregulation of connexin43 contributes to PX-12-induced oxidative cell death.Antioxidant response elements: Discovery, classes, regulation and potential applications.
P2860
Q34276504-9A269E6D-301C-4395-AFF3-06FBFC114A99Q35103126-30826D2A-4902-4D56-B7A9-D18C1871EE5AQ35448249-185FD9BC-8391-4EC3-BB3C-B49941B5C2CAQ35987083-C9FB75C6-AD9C-4577-BBAF-94F3204E1343Q36220497-9E2A27DE-A215-47A7-B13D-9B7B3F8953A0Q36475493-DA8489A9-2297-45B4-8C27-04D1B0CE0124Q36951822-EA7ED686-7675-4BFC-993A-153B6D5CC7EAQ37414462-837D21D7-FBC8-4E80-A318-E3D85EDE4DEEQ38812090-069F2BE0-A64A-4892-A017-770044FEBBD9Q38825960-C609B545-3CF8-4993-8F9A-7A03B53DD51DQ39393740-62C426B7-5A12-4641-8E8E-55BBDB088942Q46539217-B1024005-071C-4D5B-9169-94BD538C1FD1Q51559766-BE296BE9-4D24-4FB7-BDBD-43D1C282EE14Q51600585-F418876A-61B2-4699-AB29-79BA4EB4FB19Q55484374-85513011-4278-4264-92D2-F006D8C6FC2F
P2860
Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@ast
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@en
type
label
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@ast
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@en
prefLabel
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@ast
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@en
P2093
P2860
P1476
Antitumor agent PX-12 inhibits ...... e/spermine acetyl transferase.
@en
P2093
Amanda F Baker
Yon Hui Kim
P2860
P2888
P304
P356
10.1007/S00280-010-1500-0
P50
P577
2010-11-11T00:00:00Z